References
- Zerhouni E. Medicine. The NIH Roadmap. Science 2003; 302(5642)63–72
- Webb S. The contribution, history, impact and future of physics in medicine. Acta Oncol 2008.
- Brahme A, Ågren AK. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 1987; 26: 377–85
- Levin-Plotnik D, Hamilton RJ. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols. Phys Med Biol 2004; 49: 407–24
- Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol 1994; 39: 1895–914
- Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993; 38: 653–66
- Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, Koutcher JA. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000; 47: 551–60
- Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005; 6: 112–7
- Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683–93
- Weissleder R. Molecular imaging: Exploring the next frontier. Radiology 1999; 212: 609–14
- Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007; 25: 953–64
- Jakel O, Schulz-Ertner D, Karger CP, Nikoghosyan A, Debus J. Heavy ion therapy: Status and perspectives. Technol Cancer Res Treat 2003; 2: 377–87